Sex-specific metabolic pathways associate with Alzheimer’s Disease (AD) endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery cohort
Jin Xu, Rebecca Green, Min Kim, View ORCID ProfileJodie Lord, Amera Ebshiana, Sarah Westwood, Alison L Baird, Alejo J Nevado-Holgado, Liu Shi, Abdul Hye, Stuart G. Snowden, Isabelle Bos, Stephanie J. B. Vos, Rik Vandenberghe, Charlotte E. Teunissen, Mara Ten Kate, View ORCID ProfilePhilip Scheltens, Silvy Gabel, Karen Meersmans, Olivier Blin, Jill Richardson, Ellen Elisa De Roeck, View ORCID ProfileSebastiaan Engelborghs, Kristel Sleegers, Régis Bordet, Lorena Rami, Petronella Kettunen, Magda Tsolaki, Frans R.J. Verhey, View ORCID ProfileDaniel Alcolea, Alberto Lleó, Gwendoline Peyratout, Mikel Tainta, Peter Johannsen, Yvonne Freund-Levi, Lutz Frölich, Valerija Dobricic, Giovanni B. Frisoni, José Luis Molinuevo, Anders Wallin, Julius Popp, Pablo Martinez-Lage, Lars Bertram, Kaj Blennow, Henrik Zetterberg, Johannes Streffer, View ORCID ProfilePieter Jelle Visser, Simon Lovestone, View ORCID ProfilePetroula Proitsi, Cristina Legido-Quigley on behalf of EMIF Consortium
doi: https://doi.org/10.1101/2021.04.06.21254535
Jin Xu
1Institute of Pharmaceutical Science, King’s College London, London, United Kingdom
2Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King’s College London, London, United Kingdom
Rebecca Green
2Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King’s College London, London, United Kingdom
3NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Trust, London, United Kingdom
Min Kim
4Steno Diabetes Center, Gentofte, Denmark
Jodie Lord
2Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King’s College London, London, United Kingdom
Amera Ebshiana
1Institute of Pharmaceutical Science, King’s College London, London, United Kingdom
Sarah Westwood
5Department of Psychiatry, University of Oxford, Oxford, United Kingdom
Alison L Baird
5Department of Psychiatry, University of Oxford, Oxford, United Kingdom
Alejo J Nevado-Holgado
5Department of Psychiatry, University of Oxford, Oxford, United Kingdom
Liu Shi
5Department of Psychiatry, University of Oxford, Oxford, United Kingdom
Abdul Hye
2Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King’s College London, London, United Kingdom
Stuart G. Snowden
1Institute of Pharmaceutical Science, King’s College London, London, United Kingdom
Isabelle Bos
6Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
7Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Centrum Limburg, Maastricht University, Maastricht, Netherlands
Stephanie J. B. Vos
7Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Centrum Limburg, Maastricht University, Maastricht, Netherlands
Rik Vandenberghe
6Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
Charlotte E. Teunissen
8Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands
Mara Ten Kate
6Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
8Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands
Philip Scheltens
6Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
Silvy Gabel
9Department of Clinical Chemistry, Neurochemistry Laboratory, Amsterdam Neuroscience, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands
10Department of Neurosciences, Laboratory for Cognitive Neurology, Leuven, Belgium
11University Hospital Leuven, Leuven, Belgium
Karen Meersmans
10Department of Neurosciences, Laboratory for Cognitive Neurology, Leuven, Belgium
11University Hospital Leuven, Leuven, Belgium
Olivier Blin
12Aix-Marseille University-CNRS, Marseille, France
Jill Richardson
13Neurosciences Therapeutic Area, GlaxoSmithKline R&D, Stevenage, United Kingdom
Ellen Elisa De Roeck
14Vrije Universiteit Brussel, Brussels, Belgium
15Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
Sebastiaan Engelborghs
15Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
16Department of Neurology and Center for Neurosciences (C4N), UZ Brussel and Vrije Universiteit Brussel (VUB), Brussels, Belgium
Kristel Sleegers
17Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
18Complex Genetics of Alzheimer’s Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
Régis Bordet
19Université de Lille, Lille, France
Lorena Rami
20Alzheimer’s Disease and Other Cognitive Disorders Unit, Hospital Clínic of Barcelona, IDIBAPS, Barcelona, Spain
Petronella Kettunen
21Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Magda Tsolaki
22AHEPA University Hospital, Thessaloniki, Greece
Frans R.J. Verhey
23Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands
Daniel Alcolea
24Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Alberto Lleó
24Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Gwendoline Peyratout
25Lausanne University Hospital, Lausanne, Switzerland
Mikel Tainta
26Fundación CITA-Alzhéimer Fundazioa, San Sebastian, Spain
Peter Johannsen
27Danish Dementia Research Centre, Rigshospitalet, Copenhagen, Denmark
Yvonne Freund-Levi
28Department of Neurobiology, Caring Sciences and Society (NVS), Division of Clinical Geriatrics, Karolinska Institutet, Department of Psychiatry in Region Örebro County and School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
29Department of Old Age Psychiatry, Psychology & Neuroscience, King’s College, London, UK
Lutz Frölich
30Department of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
Valerija Dobricic
31Lübeck Interdisciplinary Platform for Genome Analytics, Institutes of Neurogenetics and Cardiogenetics, University of Lübeck, Lübeck, Germany
Giovanni B. Frisoni
32University of Geneva, Geneva, Switzerland
33IRCCS Fatebenefratelli, Brescia, Italy
José Luis Molinuevo
34Barcelona Beta Brain Research Center, Unversitat Pompeu Fabra, Barcelona, Spain
35University of Lille, Lille, France
Anders Wallin
21Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Julius Popp
36Old Age Psychiatry, Department of Psychiatry, University Hospital Lausanne, Lausanne, Switzerland
37Department of Geriatric Psychiatry, University Hospital of Psychiatry Zürich, Zürich, Switzerland
Pablo Martinez-Lage
38Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, San Sebastian, Spain
Lars Bertram
39University of Oslo, Oslo, Norway
40University of Lübeck, Lübeck, Germany
Kaj Blennow
41Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
42Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden
Henrik Zetterberg
41Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
43Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden
44UK Dementia Research Institute at UCL, London, United Kingdom
45Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom
Johannes Streffer
15Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
Pieter Jelle Visser
46Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands
47Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
Simon Lovestone
5Department of Psychiatry, University of Oxford, Oxford, United Kingdom
48Janssen-Cilag UK Ltd, Oxford, United Kingdom
Petroula Proitsi
2Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King’s College London, London, United Kingdom
Cristina Legido-Quigley
1Institute of Pharmaceutical Science, King’s College London, London, United Kingdom
4Steno Diabetes Center, Gentofte, Denmark
- Supplementary document[supplements/254535_file02.pdf]
Posted July 05, 2021.
Sex-specific metabolic pathways associate with Alzheimer’s Disease (AD) endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery cohort
Jin Xu, Rebecca Green, Min Kim, Jodie Lord, Amera Ebshiana, Sarah Westwood, Alison L Baird, Alejo J Nevado-Holgado, Liu Shi, Abdul Hye, Stuart G. Snowden, Isabelle Bos, Stephanie J. B. Vos, Rik Vandenberghe, Charlotte E. Teunissen, Mara Ten Kate, Philip Scheltens, Silvy Gabel, Karen Meersmans, Olivier Blin, Jill Richardson, Ellen Elisa De Roeck, Sebastiaan Engelborghs, Kristel Sleegers, Régis Bordet, Lorena Rami, Petronella Kettunen, Magda Tsolaki, Frans R.J. Verhey, Daniel Alcolea, Alberto Lleó, Gwendoline Peyratout, Mikel Tainta, Peter Johannsen, Yvonne Freund-Levi, Lutz Frölich, Valerija Dobricic, Giovanni B. Frisoni, José Luis Molinuevo, Anders Wallin, Julius Popp, Pablo Martinez-Lage, Lars Bertram, Kaj Blennow, Henrik Zetterberg, Johannes Streffer, Pieter Jelle Visser, Simon Lovestone, Petroula Proitsi, Cristina Legido-Quigley
medRxiv 2021.04.06.21254535; doi: https://doi.org/10.1101/2021.04.06.21254535
Sex-specific metabolic pathways associate with Alzheimer’s Disease (AD) endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery cohort
Jin Xu, Rebecca Green, Min Kim, Jodie Lord, Amera Ebshiana, Sarah Westwood, Alison L Baird, Alejo J Nevado-Holgado, Liu Shi, Abdul Hye, Stuart G. Snowden, Isabelle Bos, Stephanie J. B. Vos, Rik Vandenberghe, Charlotte E. Teunissen, Mara Ten Kate, Philip Scheltens, Silvy Gabel, Karen Meersmans, Olivier Blin, Jill Richardson, Ellen Elisa De Roeck, Sebastiaan Engelborghs, Kristel Sleegers, Régis Bordet, Lorena Rami, Petronella Kettunen, Magda Tsolaki, Frans R.J. Verhey, Daniel Alcolea, Alberto Lleó, Gwendoline Peyratout, Mikel Tainta, Peter Johannsen, Yvonne Freund-Levi, Lutz Frölich, Valerija Dobricic, Giovanni B. Frisoni, José Luis Molinuevo, Anders Wallin, Julius Popp, Pablo Martinez-Lage, Lars Bertram, Kaj Blennow, Henrik Zetterberg, Johannes Streffer, Pieter Jelle Visser, Simon Lovestone, Petroula Proitsi, Cristina Legido-Quigley
medRxiv 2021.04.06.21254535; doi: https://doi.org/10.1101/2021.04.06.21254535
Subject Area
Subject Areas
- Addiction Medicine (280)
- Allergy and Immunology (580)
- Anesthesia (141)
- Cardiovascular Medicine (1963)
- Dermatology (187)
- Emergency Medicine (335)
- Epidemiology (11123)
- Gastroenterology (629)
- Genetic and Genomic Medicine (3199)
- Geriatric Medicine (310)
- Health Economics (567)
- Health Informatics (2050)
- Health Policy (864)
- Hematology (310)
- HIV/AIDS (685)
- Medical Education (318)
- Medical Ethics (92)
- Nephrology (337)
- Neurology (3004)
- Nursing (165)
- Nutrition (465)
- Oncology (1562)
- Ophthalmology (478)
- Orthopedics (186)
- Otolaryngology (266)
- Pain Medicine (202)
- Palliative Medicine (57)
- Pathology (403)
- Pediatrics (914)
- Primary Care Research (355)
- Public and Global Health (5614)
- Radiology and Imaging (1101)
- Respiratory Medicine (764)
- Rheumatology (341)
- Sports Medicine (289)
- Surgery (348)
- Toxicology (48)
- Transplantation (159)
- Urology (133)